Trial Details

Recruiting
Basic Information
Clinical ID c3046
Identifier DRKS00006810
Trial Title Stool -therapy for inflammatory bowel disease
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions A04.7;Enterocolitis due to Clostridium difficile;A04.7
Interventions Group 1: In dependence on the patients request, two stool-administration routes are offered: 1) Application via a nasoduodenale probe or 2) application via the endoscope during the Koloscopy (in the absence of decision by the patient or, in the case of an increased risk when performing a Koloscopy is the patient a duodenal application recommended). As a first step, the application is carried out by frozen stool, which was collected and frozen in advance of a healthy subject. The infusion mix is thawed only immediately before application. After therapy, patients are observed 24hours stationary and leave the hosptital with a stable clinical condition in the outpatient care, in so far as there are no other indications for inpatient treatment, dismissed. The follow-up of patients is provided for 90 days after therapy. C. difficile toxin stool test performed on days 14, 30, 90 or upon the occurrence of diarrhea. Sonographic examinations carried out for each bowel Visit the patient or on the same days as the CDI stool tests.
Participant Information
Sponsor Universitsklinik f Gastroenterologie, Hepatologie und Infektiologie
City -
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, ELDER, OLDER_ADULT
Study Design
Study Type interventional
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -